5/22/24 16:33 | 5/20/24 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Stump David C | MD | D | | M.d | 0 | 0.00 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
7/26/12 09:00 | 7/24/12 | HGSI | Human Genome Sciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stump David C | MD | O | Exec. VP | M.d | 426 | 6.20 | 0 | 69 | 351 | 88 | D | | | | | | | | | | | | | | |
4/1/10 15:49 | 4/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | M.d | 427 | 12.56 | 33 | 34 | | 20 | D | 393 | 999 | 60 | -2 | 3 | -8 | -3 | -2 | 2 | 7 | -8 | -25 | -5 | -9 |
4/1/10 15:49 | 4/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,044 | 30.72 | 33 | -34 | -63 | 20 | D | 393 | 999 | 60 | -2 | 3 | -8 | -3 | -2 | 2 | 7 | -8 | -25 | -5 | -9 |
3/2/10 13:15 | 3/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | M.d | 628 | 12.56 | 33 | 50 | | 20 | D | 385 | 999 | 57 | 7 | 2 | 16 | 2 | 4 | 1 | 4 | 4 | -17 | -2 | -16 |
3/2/10 13:15 | 3/1/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,404 | 28.07 | 33 | -50 | -72 | 20 | D | 385 | 999 | 57 | 7 | 2 | 16 | 2 | 4 | 1 | 4 | 4 | -17 | -2 | -16 |
2/2/10 17:17 | 2/2/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | M.d | 628 | 12.56 | 33 | 50 | | 20 | D | 394 | 999 | 93 | 38 | 1 | -9 | -1 | -2 | -1 | -8 | 11 | 1 | -6 | -14 |
2/2/10 17:17 | 2/2/10 | HGSI | Human Genome Sciences Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stump David C | MD | O | Exec. VP | S.d | -1,370 | 27.40 | 33 | -50 | -72 | 20 | D | 394 | 999 | 93 | 38 | 1 | -9 | -1 | -2 | -1 | -8 | 11 | 1 | -6 | -14 |